Inivata and collaborators to present data that further validate the application of its RaDaR™ MRD and InVisionFirst®-Lung assays at the ESMO Congress 2021

NEXT STORY
Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis
PREV STORY
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBI Vaccines Completes Vaccination in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine

Vaccination complete in 1,537 subjects in PROTECT Phase 3 studyNo vaccine-related adverse events have ...

author_avatar
NASDAQ Market News

Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors

BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP) today announced that ...

author_avatar
NASDAQ Market News

Immunotech Laboratories, Inc. / ECPO Year End Update and Announces Appointment of Dr. Hongxiang Hui to the Advisory Board

MONROVIA, CA, Dec. 22, 2017 (GLOBE NEWSWIRE) --  Immunotech Laboratories, Inc. f/k/a Eco-Petroleum Solutions, ...

author_avatar
NASDAQ Market News